Newcourt, Psyence SPAC merger approved but may not close (NASDAQ:NCAC)


SPAC Newcourt Acquisition Corp. (NASDAQ:NCAC) shareholders have voted to approve a planned merger with psilocybin therapy developer Psyence Biomed (OTCQB:PSYGF), but the deal may not be able to close by Newcourt’s charter deadline of Jan. 22.

Newcourt disclosed the mergerin an SEC filingan SEC filing on Monday

Source link

Related Articles

Back to top button